Surgery or Endoprosthesis for Malignant Obstructive Jaundice by Matthews, Jeffrey B.
HPB INTERNATIONAL 369
in a clinical investigation would be to include only potential transplant candidates at
the outset. Ideally, such a study would be randomized with one arm including patients
who either underwent initial hepatic transplantation or transplantation after
sclerotherapy failure and the second arm consisting ofindividuals who would receive a
shunt operation after sclerotherapy if their hepatic functional reserve was well
maintained. This group would then undergo transplantation as a back-up to shunt
surgery when end-stage liver disease was apparent. Because many variceal bleeders are
not candidates for hepatic transplantation, it would be difficult to accrue a sufficient
number of patients to such an investigation to provide meaningful results.
Layton F. Rikkers, M.D.
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SURGERY OR ENDOPROSTHESIS FOR MALIGNANT
OBSTRUCTIVE JAUNDICE
ABSTRACT
Shepherd HA, Royle G, Ross APR, Diba A, Arthur M and Colin-Jones D (1988)
Endoscopic biliary endoprosthesis in the palliation ofmalignant obstruction of the distal
common bile duct." a randomized trial. British Journal ofSurgery; 75.’1166-1168
A total of 52 jaundiced elderly patients who had malignant obstruction of the distal
common bile duct and who required palliative biliary decompression were randomized to370 HPB INTERNATIONAL
receive either an endoscopically placed biliary endoprosthesis (10 French gauge) or
conventional surgical bypass. Patients within the two treatment groups were well matched
and 51 were followed until their death. Patients treated with endoprosthesis had a
significantly shorter initial hospital stay than those treated surgically. In the long term,
overall survival in the two groups was similar andjaundice was relieved in over 90 per cent
of patients. Despite more re-admissions to hospital for those patients treated
endoscopicaily, the total time spent in hospital still remained significantly shorter in this
treatment group compared with those subjected to surgery. The endoscopically placed
biliary endoprosthesis is a valuable alternative to conventional surgical bypass in the
palliation of extrahepatic biliary obstruction.
PAPER DISCUSSION
KEYWORDS: Pancreas, carcinoma; jaundice, obstructive; endoprosthesis; surgical
bypass
Amidst the plethora of published uncontrolled studies of surgical, endoscopic, and
percutaneous approaches to the palliation of malignant obstruction of the distal
common bile duct, Shepherd and coworkers are to be congratulated for reporting the
first randomized trial comparing endoscopic biliary endoprosthesis to surgical bypass
in a selected group of 52 elderly jaundiced patients.
The recent trend exploring the use of nonoperative techniques may largely be
attributed to the generally disappointing results of either surgical resection or bypass
for adenocarcinoma of the head of the pancreas, and early nonrandomized reports
have suggested that transhepatic percutaneous or endoscopic intubation techniques
may offer equivalent relief of jaundice with comparable survival rates2’3’4’5. The
prospective controlled trial reported by the Capetown group demonstrated no
significant difference between the palliation afforded by surgical bypass or trans-
hepatically-introduced endoprosthesis6. It has been suggested previously, based on the
randomized trial from Middlesex and London Hospitals, that the endoscopic
approach may be superior to the transhepatic route for distalcommon bile duct lesions
in terms of relief of jaundice and 30-day mortality7. In this context, a controlled
comparison between endoscopic and surgical methods of palliation has been eagerly
anticipated. Although the report of Shepherd strongly supports the continued use of
endoscopic stenting for high-risk elderly patients, a note ofcaution is perhaps in order,
lest the continued important place oftraditional surgical techniques be lost underneath
a wave of enthusiasm for nonoperative approaches.
Cytologic or biopsy confirmation of adenocarcinoma of the pancreas should be
obtained before the possibility of resectional therapy be denied to a good-risk patient.
Five year survival rates after Whipple pancreaticoduodenectomy for pancreatic cancer
are dismal, generally less than 100/08’9’10’11, and many centers have therefore abandoned
hope of curative resection for this lesion except in highly selected patients. Such
pessimism, however, is not warranted for other malignant lesions of the pancreatic
head may cause obstruction of the distal common bile duct. For example, five year
0 survival after resection for distal bile duct cancer is approximately 20 Vo and may be as
8912 high as 50% for adenocarcinoma of the ampulla" The operative morbidity and
mortality of"pancreaticoduodenectomy is no longer prohibitive in experienced hands.
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differentiated with confidence on radiologic grounds alone, and while fine-needle
aspiration cytology appears to represent an important advance in diagnostic ability, it
is still often inconclusive. Open biopsy therefore continues to be required as a
diagnostic modality, and, in any event, the resectability of a given pancreatic head
lesion is most accurately determined at surgical exploration. It remains incumbent on
the gastroenterologist or surgeon to exclude with certainty the presence of more
favorable lesions amenable to potentially curative resection before embarking on a
purely palliative approach.
Criteria for patient selection in controlled trials must be carefully defined, and it is
important to note that in the report by Shepherd, the presence of duodenal
encroachment, portal venous compromise, disseminated malignancy, carcinoma ofthe
papilla, and failed ERCP were appropriately considered grounds for exclusion.
According to the presented data, 20 of72 patients (28%) referred for investigation were
excluded (18 patients who received nonrandomized treatment were also omitted from
consideration). Because the protocol allowed for crossover between groups, four
patients who failed endoscopic placement and two surgical failures were managed by
the alternative technique. While technical success was achieved in a respectable 82% of
endoscopically treated patients, it is surprising that there were two patients in the
surgical group in whom anatomic considerations were reported to preclude the
construction of a satisfactory anastomosis. In our experience at Hammersmith
Hospital and the University of Berne, failure to achieve an adequate biliary bypass is
rare; thorough knowledge of hepatobiliary anatomy almost always allows sufficient
exposure of the common hepatic or extrahepatic left hepatic duct, or more rarely a
segmental bile duct exposed via the umbilical fissure in those unusual cases where
tumor involves the supraduodenal common bile duct or gallbladder. In addition, the
choice of surgical bypass performed in this report and others may be criticized. Many
experienced hepatobiliary surgeons now prefer Roux-en-Y choledocho-jejunostomy
or hepaticojejunostomy for biliary-enteric anastomosis to reconstruction utilizing the
gallbladder13, which was chosen in over half of the surgically managed cases in this
series. A surgical complication rate greater than 50% seems excessive, although there
was no statistical difference in complication rates between the surgical and endoscopic
groups. It is interesting to note that no patient in the stented group developed gastric
outlet obstruction prior to death. The additional morbidity involved in gastro-
jejunostomy is fairly negligible, but the value of routine gastric bypass has long
remained a controversial point among surgeons14’5.
The inevitable difficulty inherent in interpretation of studies asserting that an
alternative therapeutic modality is "as good as" conventional techniques is the
ubiquitous type II statistical error, and it is disappointing that the relatively small
number ofpatients reported in the present series demonstrated few points ofdifference
between the two study groups. This problem is usually unavoidable in trials examining
treatment of uncommon lesions, but it may be hoped that as experience with
nonoperative approaches to malignant bile duct obstruction accumulates, statistical
significance will emerge. The current report consists of only a three year study period.
One important point of statistical significance did emerge, however. Total hospital
days for the endoscopically managed group, including total days of readmissions, was
lower than the surgically treated group. However, it may equally convincingly be
argued that, in terms of quality of palliation, fewer total hospital admissions and
freedom from cholangitis may be a more desirable endpoint. Indeed, there was a trend
favoring fewer readmissions for the surgically managed patients (13 readmissions for
cholangitis in 23 stented patients compared to 3 for 25 operated patients).372 HPB INTERNATIONAL
Despite the use oflarge-bore prostheses, the problem oflate cholangitis has not been
eliminated. Although planned routine stent replacement may minimize the morbidity
of this complication, many surgeons argue that the invariably high incidence of
endoprosthesis occlusion and cholangitis weighs strongly against routine use of the
endoscopic option for routine palliative purposes and that this approach should be
reserved for only the most debilitated and elderly patients. While significant surgical
morbidity in jaundiced, nutritionally-depleted patients appears similarly unavoidable,
with meticulous operative technique and proper choice of procedure, the early
complication rate should probably not exceed 30%, and late complications should be
unusual. It must also be recognized that both endoscopic and percutaneous
approaches also carry an approximately 30% periprocedural complication rate even in
expert hands.
Surgical and endoscopic methods of palliation all offer at least temporary relief of
jaundice in over 90% of patients, and therefore a nihilistic approach to palliation
appears unjustified. Neither approach can be argued to yield superior longterm
survival in available controlled or uncontrolled reports. Therefore the choice of
palliative approach to the management ofmalignant obstruction of the distal common
bile duct in elderlyjaundiced patients must remain individualized, dictated by available
local expertise and the preferences of well-informed patients and clinicians.
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